Alzheimer Society of Canada

'Landmark' study projects 187% increase in people living with dementia in Canada by 2050, stresses urgent need to work collaboratively toward equity, diversity and inclusion in research, prevention and care

Retrieved on: 
Monday, January 22, 2024

The Landmark Study: The Many Faces of Dementia in Canada is the second of three volumes detailing the demographic, social and economic impact of dementia in Canada.

Key Points: 
  • The Landmark Study: The Many Faces of Dementia in Canada is the second of three volumes detailing the demographic, social and economic impact of dementia in Canada.
  • With the rapid rise of Canada's aging population, the study projects that the number of people living with dementia in the country will increase by 187% by 2050.
  • "We have to work together to make diversity and inclusion part of a more holistic approach to dementia prevention and management," said Natasha Jacobs, Advisory Group Lead, Alzheimer Society of Canada.
  • In 2020, an estimated 61.8% of persons living with dementia in Canada were female and more than half of care partners were women.

Alzheimer Society Research Program now open

Retrieved on: 
Friday, September 8, 2023

TORONTO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Each year, the Alzheimer Society Research Program funds the best and brightest dementia researchers across Canada by providing millions of dollars in awards and grants.

Key Points: 
  • TORONTO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Each year, the Alzheimer Society Research Program funds the best and brightest dementia researchers across Canada by providing millions of dollars in awards and grants.
  • The Alzheimer Society Research Program (ASRP) is led by the Alzheimer Society of Canada, with lead partner Brain Canada Foundation, and support from Saskatchewan Health Research Foundation and Fonds de recherche du Québec – Santé.
  • “The ASRP is one of our flagship initiatives each year,” said Dr. Louise Scrocchi, Research Executive, Alzheimer Society of Canada.
  • “We take great pride in collaborating with our partners, including Alzheimer Society of Canada, to support and drive groundbreaking research in the field of dementia,” says Dr. Viviane Poupon, President and CEO of Brain Canada.

Alzheimer Society of Canada invests nearly $6 million to support innovative dementia research

Retrieved on: 
Thursday, July 20, 2023

“We are setting the standard for dementia research in this country,” says Christopher Barry, Chief Executive Officer, Alzheimer Society of Canada.

Key Points: 
  • “We are setting the standard for dementia research in this country,” says Christopher Barry, Chief Executive Officer, Alzheimer Society of Canada.
  • The Alzheimer Society Research Program is changing dementia research in Canada.
  • This funding has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada), Brain Canada Foundation, and Alzheimer Society of Canada.
  • The Alzheimer Society Research Program funds dementia research across Canada.

Development in Alzheimer's disease diagnosis in Canada: New tests help patients and caregivers make timely decisions

Retrieved on: 
Thursday, June 8, 2023

These play a role in normal brain function; abnormal levels of these proteins are directly related to Alzheimer's disease.

Key Points: 
  • These play a role in normal brain function; abnormal levels of these proteins are directly related to Alzheimer's disease.
  • In AD, measuring changes in biomarkers can help medical teams understand how quickly a patient's condition may be advancing, and potentially, predict how it may develop in the future.
  • Earlier and more accurate diagnoses allow patients to be aware of their AD progress and to adopt appropriate lifestyle changes while preparing for the future.
  • Since cognitive decline may be misinterpreted as a normal characteristic of aging, early diagnosis through biomarkers would help facilitate the identification of patients facing cognitive decline as a result of AD."

Alzheimer Society of Ontario Applauds First Step Towards Approved Treatment for Alzheimer’s Disease in Canada

Retrieved on: 
Wednesday, May 17, 2023

If approved, Leqembi would be Canada’s first treatment for Alzheimer’s disease—not just its symptoms.

Key Points: 
  • If approved, Leqembi would be Canada’s first treatment for Alzheimer’s disease—not just its symptoms.
  • “Two years ago the world had no approved treatments for Alzheimer’s disease.
  • It is vital that we get the introduction of this first treatment right.”
    Research out of the University of Southern California released last year, sponsored by the Alzheimer Society of Ontario, found that Ontario is not ready for the now-foreseeable arrival of an approved treatment for Alzheimer’s disease.
  • To be most effective Leqembi, along with two other promising treatments for Alzheimer’s disease, must be administered early in disease progression.

IG Wealth Management Walk for Alzheimer’s Returns

Retrieved on: 
Wednesday, May 3, 2023

TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- On the weekend of May 27-28, Canadians from coast-to-coast will once again lace up their shoes for the IG Wealth Management Walk for Alzheimer’s (“the Walk”), the country’s largest fundraiser in support of the more than 600,000 people in Canada living with dementia, their families, friends and caregivers.

Key Points: 
  • TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- On the weekend of May 27-28, Canadians from coast-to-coast will once again lace up their shoes for the IG Wealth Management Walk for Alzheimer’s (“the Walk”), the country’s largest fundraiser in support of the more than 600,000 people in Canada living with dementia, their families, friends and caregivers.
  • Now in its eighth year as a national event, the IG Wealth Management Walk for Alzheimer’s has raised more than $41 million to fund life-changing Alzheimer Society programs and services that help people affected by dementia.
  • “Together with IG Wealth Management and thousands of supporters from coast-to-coast, we encourage Canadians to join and fundraise for their local Walk.
  • “IG is once again proud to support the Alzheimer Society in their important work to help people living with dementia and their caregivers across Canada,” said Damon Murchison, President and CEO, IG Wealth Management.

Lace up your shoes and support people living with dementia in your community

Retrieved on: 
Wednesday, May 3, 2023

It’s become more than a fundraiser — it is an event where families, people living with dementia, and the greater community feel united for a common cause” says Chandra MacBean, Executive Director of the Alzheimer Society of New Brunswick.

Key Points: 
  • It’s become more than a fundraiser — it is an event where families, people living with dementia, and the greater community feel united for a common cause” says Chandra MacBean, Executive Director of the Alzheimer Society of New Brunswick.
  • With over 12,000 New Brunswickers currently living with Alzheimer’s or another form of dementia, nearly everyone is touched by this disease, whether it be a relative, friend, neighbour, or members of your community.
  • “Our free programs bring those impacted by dementia together to learn from and support one another, and to help them to plan for the journey ahead.
  • Join us on Walk Day on May 28, 2023 – join dedicated people like you, who are committed to helping people living with dementia and caregivers.

For people living with dementia, support changes everything

Retrieved on: 
Tuesday, January 3, 2023

Alzheimer Society of Canada hopes to connect people living with dementia to support, knowledge and community

Key Points: 
  • Alzheimer Society of Canada hopes to connect people living with dementia to support, knowledge and community
    TORONTO, Jan. 3, 2023 /CNW/ - A diagnosis of dementia is not easy.
  • To get connected to your local Alzheimer Society for support, visit www.alzheimer.ca/FirstLink
    The Alzheimer Society is Canada's leading nationwide health charity for people living with Alzheimer's disease and other dementias.
  • Data from the CIHI has shown that:
    45% of care partners providing care to people living with dementia exhibit symptoms of distress.
  • Alzheimer Societies across Canada provide caregivers and families with information, education and resources to help them support the person in their care who is living with dementia.

Giant Tiger Supports Communities in a Million Different Ways

Retrieved on: 
Tuesday, November 29, 2022

OTTAWA, ON, Nov. 29, 2022 /CNW/ - Giant Tiger is committed to making a difference in the communities it calls home every day.

Key Points: 
  • OTTAWA, ON, Nov. 29, 2022 /CNW/ - Giant Tiger is committed to making a difference in the communities it calls home every day.
  • Giant Tiger is proud of its charitable involvement for 2022 and actively does its part to champion causes close to the hearts of the 264 communities it serves through the Giant Tiger Charitable Giving Fund, sponsorships and campaigns, store-led initiatives, and donations.
  • Some of the ways Giant Tiger gives back includes:
    The Giant Tiger Charitable Giving Fund , which provides organizations with financial support to assist with running programs that aim to feed families, promote physical and mental health or empower youth.
  • Giant Tiger also gives back with in-kind product donations to local and national organizations that are making a difference.

New interactive tool aims to help people living with mild dementia stay safe while maintaining their freedom to go where they like

Retrieved on: 
Tuesday, October 18, 2022

The website features an interactive tool that pinpoints a person's risk level for getting lost and then provides strategies tailored to that specific risk level.

Key Points: 
  • The website features an interactive tool that pinpoints a person's risk level for getting lost and then provides strategies tailored to that specific risk level.
  • "Persons living with dementia are at a higher risk of getting lost and going missing.
  • The Guideline simplified the more than 300 types of strategies for persons with dementia at risk of getting lost.
  • The website tool asks six questions to assess anindividual's personal risk level of getting lost whether low, medium or high risk.